Why the biopharma M&A market is ready for takeoff

The latest stories trending on MedCity News.

Editor's Pick

Top Story 3 Reasons Why The Biopharma M&A Market Is Ready For Takeoff Healthcare M&A deals are expected to pick up over the next few months, and one expert is predicting that the biopharma sector in particular will see especially robust activity. M&A lawyer Matt Gardella said there are three sets of market circumstances that will lead to an influx of biopharma deals: a looming patent cliff, shrinking valuations and a weak IPO market. Sponsored Content Driving for Results: 3 Key Benefits of Telehealth Presented by Greenway Health Explore the myriad benefits telehealth offers to healthcare providers and patients alike. From enhanced convenience and improved privacy to streamlined workflows and elevated patient satisfaction, find out how telehealth is reshaping the future of healthcare delivery. Learn More>> What Do You Think? To gain a better understanding of your preferences and interests across MedCity and the entire industry, please take 3-5 minutes of your time and tell us what you think. Upon completion of the survey you can enter for a chance to win a $250 gift card. Your input is anonymous and extremely valuable. Take Survey

Featured News

Nashville Entrepreneur Center Gears Up for Virtual Care Delivery Conference September 21 Telehealth Academy III, a conference exploring the virtual care delivery landscape, will be one of the highlights of an inaugural week of events organized in the healthcare provider hub of Nashville, referred to as Nashville Healthcare Sessions. Genesis Therapeutics Rakes In $200M For AI-Powered Drug Discovery Genesis Therapeutics recently joined the growing list of AI-powered drug discovery startups receiving venture funding this year. The company closed a $200 million Series B financing round, taking its total funding to date to more than $280 million. Viome Life Sciences Secures $86.5M for At-home Tests and Health Products Viome Life Sciences' Series C funding round included participation from Khosla Ventures, Bold Capital and WRG Ventures. In total, Viome has raised $175 million. Prediction is Power: The Truth About What is AI, Really Do some people simply think the A in AI stands for Automation? Most likely the confusion is due to a lack of understanding of what AI truly is, combined with a strong desire to use the term for marketing purposes. Prioritizing SDOH for Patients Living with Chronic Diseases: Compassion, Coordination and Community As the U.S. healthcare system works to focus on the move to preventive, personalized care for patients, it's time to turn the tide on diabetes by addressing the three Cs of chronic disease care: compassion, coordination, and community. Spring Health Launches Mental Health Education Platform for Workplaces Spring Health launched Sage, a platform that offers asynchronous video lessons to help employees manage their own mental health and support managers in creating a healthy work environment. A More Predictive and Preventive Cardiothoracic Imaging Interpretation Model to Avoid Delayed Diagnoses The current imaging interpretation model undoubtedly has reached its breaking point due to increasing volumes and fewer radiologists. The time is now to solve this systemic imaging interpretation issue.

Resources

AI in Healthcare: Scratching the Surface Learn how AI is transforming the healthcare industry and the pitfalls that also exist with its early adoption. Download Now

MedCity News • PO Box 901 • New York, NY unsubscribe